Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 177-185 , July 2006

Chemoradiotherapy in the Treatment of Cervical Cancer

  • Patricia J. Eifel, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Patricia J. Eifel, MD, Department of Radiation Oncology, Unit 1202, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030.

References 

  1. Morris M , Eifel PJ , Lu J , et al.   Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer . N Engl J Med . 1999;340:1137–1143
  2. Rose PG , Bundy BN , Watkins J , et al.   Concurrent cisplatin-based chemotherapy and radiotherapy for locally advanced cervical cancer . N Engl J Med . 1999;340:1144–1153
  3. Keys HM , Bundy BN , Stehman FB , et al.   Cisplatin, radiation, and adjuvant hysterectomy for bulky stage IB cervical carcinoma . N Engl J Med . 1999;340:1154–1161
  4. Whitney CW , Sause W , Bundy BN , et al.   A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB–IVA carcinoma of the cervix with negative para-aortic lymph nodes (A Gynecologic Oncology Group and Southwest Oncology Group study) . J Clin Oncol . 1999;17:1339–1348
  5. Eifel PJ . Concurrent chemotherapy and radiation (A major advance for women with cervical cancer) . J Clin Oncol . 1999;17:1334–1335
  6. Eifel PJ , Moughan J , Erickson B , et al.   Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix (A patterns of care study) . Int J Radiat Oncol Biol Phys . 2004;60:1144–1153
  7. Souhami L , Gil R , Allan S , et al.   A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix . Int J Radiat Oncol Biol Phys . 1991;9:970–997
  8. Chauvergne J , Rohart J , Héron JF , et al.   Essai randomisé de chimiothérapie initiale dans 151 carcinomes du col utérin localement étendus (T2b-N1, T3b, MO) . Bull Cancer . 1990;77:1007–1024
  9. Tattersall MHN , Larvidhaya V , Vootiprux V , et al.   Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer . Am J Clin Oncol . 1995;13:444–451
  10. Kumar L , Kaushal R , Nandy M , et al.   Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer (A randomized study) . Gynecol Oncol . 1994;54:307–315
  11. Leborgne F , Leborgne JH , Doldán R , et al.   Induction chemotherapy and radiotherapy of advanced cancer of the cervix (A pilot study and phase III randomized trial) . Int J Radiat Oncol Biol Phys . 1997;37:343–350
  12. Tattersall MHN , Ramirez C , Coppleson M . A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer . Int J Gynecol Cancer . 1992;2:244–251
  13. Sundfør K , Trope CG , Hogberg T , et al.   Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A . Cancer . 1996;77:2371–2378
  14. Lanciano R , Calkins A , Bundy BN , et al.   Randomized comparison of weekly cisplatin or protracted venous infusion fluorouracil in combination with pelvic radiation in advanced cervix cancer (A Gynecologic Oncology Group Study) . J Clin Oncol . 2005;23:8277–8279
  15. Peters WA , Liu PY , Barrett RJ , et al.   Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix . J Clin Oncol . 2000;18:1606–1613
  16. Pearcey R , Brundage M , Drouin P , et al.   Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix . J Clin Oncol . 2002;20:966–972
  17. Eifel PJ , Winter K , Morris M , et al.   Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer (An update of Radiation Therapy Oncology Group trial (RTOG) 90-01) . J Clin Oncol . 2004;22:872–880
  18. Hreshchyshyn MM , Aron BS , Boronow RC , et al.   Hydroxyurea or placebo combined with radiation to treat stages IIIB and IV cervical cancer confined to the pelvis . Int J Radiat Oncol Biol Phys . 1979;5:317–322
  19. Pearcey R , Brundage M , Drouin P , et al.   A clinical trial comparing concurrent cisplatin and radiation therapy versus radiation alone for locally advanced squamous cell carcinoma of the cervix carried out by the National Cancer Institute of Canada Clinical Trials Group . Proc Am Soc Clin Oncol . 2000;19:378a
  20. Rotman M , Pajak M , Choi K , et al.   Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20 . JAMA . 1995;274:387–393
  21. Lorvidhaya V , Chitapanarux I , Sangruchi S , et al.   Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix (A randomized trial) . Int J Radiat Oncol Biol Phys . 2003;55:1226–1232
  22. Thomas G , Dembo A , Ackerman I , et al.   A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer . Gynecol Oncol . 1998;69:137–145
  23. Ludgate SM , Crandon AJ , Hudson CN , et al.   Synchronous 5-fluorouracil, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix . Int J Radiat Oncol Biol Phys . 1988;15:893–899
  24. Malviya VK , Deppe G , Kim Y , et al.   Concurrent radiation therapy, cis-platinum, and mitomycin C in patients with poor prognosis cancer of the cervix (A pilot study) . Am J Clin Oncol . 1989;12:434–437
  25. Evans LS , Kersh CR , Constable WC , et al.   Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies . Int J Radiat Oncol Biol Phys . 1988;15:901–906
  26. Nguyen PD , John B , Munoz A , et al.   Mitomycin-C/5-FU and radiation therapy for locally advanced uterine cervical cancer . Gynecol Oncol . 1991;43:220–225
  27. Thomas G , Dembo A , Beale F , et al.   Concurrent radiation, mitomycin C, and 5-fluorouracil in poor prognosis carcinoma of the cervix (Preliminary results of a phase I-II study) . Int J Radiat Oncol Biol Phys . 1984;10:1785–1790
  28. Christie DR , Bull CA , Gebski V , et al.   Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer . Radiother Oncol . 1995;37:181–189
  29. Khoury GG , Bulman AS , Joslin CA , et al.   Concomitant pelvic irradiation, 5-fluorouracil and mitomycin C in the treatment of advanced cervical carcinoma . Br J Radiol . 1991;64:252–260
  30. Roberts KB , Urdaneta N , Vera R , et al.   Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix . Int J Cancer . 2000;90:206–223
  31. Rakovitch E , Fyles AW , Pintilie M , et al.   Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix . Int J Radiat Oncol Biol Phys . 1997;38:979–987
  32. Wong LC , Choy DT , Ngan HY , et al.   4-epidoxorubicin in recurrent cervical cancer . Cancer . 1989;63:1279–1282
  33. van der Burg ME , Monfardini S , Guastalla JP , et al.   Phase II study of weekly 4′-epidoxorubicin in patients with metastatic squamous cell cancer of the cervix (an EORTC Gynaecological Cancer Cooperative Group Study) . Eur J Cancer . 1992;29A:147–148
  34. Calero F , Rodriguez-Escudero F , Jimeno J , et al.   Single agent epirubicin in squamous cell cervical cancer. A phase II trial . Acta Oncol . 1991;30:325–327
  35. Wong LC , Ngan HY , Cheung AN , et al.   Chemoradiation and adjuvant chemotherapy in cervical cancer . J Clin Oncol . 1999;17:2055–2060
  36. Bloss JD , Thigpen JT . Chemotherapy of gynecologic cancer . In:  Perry MC editors. The Chemotherapy Source Book . (ed 3). Philadelphia: Lippincott Williams & Wilkins; 2001;p. 732
  37. Douple EB , Richmond RC , O’Hara JA , et al.   Carboplatin as a potentiator of radiation therapy . Cancer Treat Rev . 1985;12(suppl A):111–124
  38. Muderspach LI , Curtin JP , Roman LD , et al.   Carboplatin as a radiation sensitizer in locally advanced cervical cancer (A pilot study) . Gynecol Oncol . 1997;65:336–342
  39. Higgins RV , Naumann WR , Hall JB , et al.   Concurrent carboplatin with pelvic radiation therapy in the primary treatment of cervix cancer . Gynecol Oncol . 2003;89:499–503
  40. Pignata S , Frezza P , Tramontana S , et al.   Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri . Ann Oncol . 2000;11:455–459
  41. Chen MD , Paley PJ , Potish RA , et al.   Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer . Gynecol Oncol . 1997;67:131–136
  42. Gaffney DK , Haslam D , Tsodikov A , et al.   Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy . Int J Radiat Oncol Biol Phys . 2003;56:922–928
  43. Brown JM . Exploiting the hypoxic cancer cell (Mechanisms and therapeutic strategies) . Mol Med Today . 2000;6:157–162
  44. Denny WA , Wilson WR . Tirapazamine (A bioreductive anticancer drug that exploits tumour hypoxia) . Expert Opin Investig Drugs . 2000;9:2889–2901
  45. Rischin D , Peters L , Fisher R , et al.   Tirapazamine, cisplatin, and radiation versus fluorouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer (A randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)) . J Clin Oncol . 2005;23:79–87
  46. Sedlis A , Bundy BN , Rotman MZ , et al.   A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy (A Gynecologic Oncology Group study) . Gynecol Oncol . 1999;73:177–183
  47. Malfetano JH , Keys H . Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases . Gynecol Oncol . 1991;42:44–47
  48. Varia MA , Bundy BN , Deppe G , et al.   Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A Gynecologic Oncology Group study . Int J Radiat Oncol Biol Phys . 1998;42:1015–1023

PII: S1053-4296(06)00008-7

doi: 10.1016/j.semradonc.2006.02.007

Seminars in Radiation Oncology
Volume 16, Issue 3 , Pages 177-185 , July 2006

Article Tools